The promotion of olanzapine in primary care: An examination of internal industry documents
- 1 July 2009
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 69 (1), 14-20
- https://doi.org/10.1016/j.socscimed.2009.05.001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Duloxetine does not relieve painful physical symptoms in depression: A meta-analysisPsychotherapy and Psychosomatics, 2007
- Building strong condition brandsJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2007
- Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One-year analysisSchizophrenia Research, 2007
- Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's DiseaseNew England Journal of Medicine, 2006
- Diabetes Risk Associated with Use of Olanzapine, Quetiapine, and Risperidone in Veterans Health Administration Patients with SchizophreniaAmerican Journal of Epidemiology, 2006
- The Fight against Disease Mongering: Generating Knowledge for ActionPLoS Medicine, 2006
- The Latest Mania: Selling Bipolar DisorderPLoS Medicine, 2006
- Giving Legs to Restless Legs: A Case Study of How the Media Helps Make People SickPLoS Medicine, 2006
- Prevalence, Correlates, and Comorbidity of Bipolar I Disorder and Axis I and II DisordersThe Journal of Clinical Psychiatry, 2005
- Cross-national epidemiology of major depression and bipolar disorderPublished by American Medical Association (AMA) ,1996